Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...
Jun 01, 2017 12:15 pm UTC| Business
PLYMOUTH MEETING, Pa., June 01, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced a clinical collaboration with Genentech, a member of the Roche Group, for advanced bladder cancer. The phase 1b/2...